How to Choose Between Human and Mouse Cell Models

• • Mouse: best for in vivo genetics, developmental timing, and experiments requiring an organism.
• • Human cells: best for relevance to human disease, human genetic variants, and drug response.
• • The practical default: establish mechanism in the system with better tools, confirm it in the system with better relevance.

For regulatory questions specifically, add one caveat: non-coding elements are less conserved than coding sequence, so a human enhancer may have no functional mouse counterpart.

Regulatory elements. Enhancer sequences diverge faster than coding sequences. A human enhancer variant may have no orthologous function in mouse, and a mouse knockout of an enhancer may show nothing.

Immune biology. Mouse and human immune systems differ substantially in receptor repertoires and cytokine networks; immune claims rarely transfer without human validation.

Metabolism. Rates, substrate preferences, and transporter expression differ; a metabolic phenotype in mouse hepatocytes may not appear in human ones.

Splicing. Isoform usage differs, so an isoform-level finding may not be conserved.

A design that works in most translational projects:

1. Discovery in the more tractable system — often human cell lines or mouse genetics, depending on the question.
2. Mechanistic confirmation in the other species — for example, human isogenic variants confirming a mouse developmental phenotype.
3. In vivo consequence where the claim requires an organism — mouse, with the caveat stated.

The third step is not mandatory for a mechanism paper, but it is for a disease-model claim.

• • State the species rationale in the methods: why this system for this claim.
• • Do not assume orthology for non-coding elements; check conservation and, where possible, test the orthologue.
• • Report species-specific findings as such rather than generalizing.
• • For human genetic variants, the human system is not optional — a mouse orthologue cannot carry a human risk allele.

EDITGENE builds human isogenic panels and mouse knockout derivatives for cross-species confirmation, including orthologous enhancer testing where conservation is uncertain.

Tell us the question and the species constraint. Contact EDITGENE to request a project consultation or quote.

Cross-species inference depends on conservation of the relevant sequence, cell type, and physiology; none should be assumed for regulatory elements.

Findings in one species should be reported as species-specific unless confirmed in the other.

• • Perlman RL. Mouse models of human disease: an evolutionary perspective. Evolution, Medicine, and Public Health. 2016;2016:170–176.
• • Cotney J, et al. The evolution of lineage-specific regulatory activities in the human embryonic limb. Cell. 2013;154:185–196.
• • Ben-David U, et al. Genetic and transcriptional evolution alters cancer cell line drug response. Nature. 2018;560:325–330.